Centogene N.V. announced Andreas Busch?s and Holger Friedrich?s decision to resign from the Company?s Supervisory Board, effective December 12, 2023. Their respective resignations were not the result of any disagreement with the Company, and are in alignment with the Company?s previously announced intention on June 27, 2023, that two representatives from Lifera, a biopharmaceutical company wholly-owned by the Public Investment Fund (PIF), will join CENTOGENE?s Supervisory Board.